PillRx only · Tablet, Film Coated · Oral
Cefpodoxime Proxetil
Cefpodoxime Proxetil
9 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US19 NDCs
9 active makers
9 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
ATC—
RxCUI (US)—
US makers9 labelers
Packages41
DEA / ScheduleNone
US acquisition costNADAC · per unit
Average across 14 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$1.271
Latest avg · Jun 17, 2026
-6%
Since Dec 17, 2025
9
Active US suppliers
54%
Top-2 supplier share*
Who makes it9 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Ascend Laboratories, LLC | unknown | 12 | SUPPLYING |
| Aurobindo Pharma Limited | unknown | 10 | SUPPLYING |
| Cronus Pharma LLC | unknown | 4 | SUPPLYING |
| AMICI PHARMA INC | unknown | 4 | SUPPLYING |
| Sandoz Inc | unknown | 4 | SUPPLYING |
| NorthStar Rx LLC | unknown | 2 | SUPPLYING |
| Golden State Medical Supply, Inc. | unknown | 2 | SUPPLYING |
| NuCare Pharmaceuticals, Inc. | unknown | 2 | SUPPLYING |
| REMEDYREPACK INC. | repackager | 1 | SUPPLYING |
Regulatory & supply events
No recalls, shortages, or registration changes on record for this drug concept.